Moore Capital Management’s Globus Medical GMED Stock Holding History

Moore Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,087	Closed	-$979K	–	733
2025 Q3	$979K	Buy	+17,087	New	+$984K	0.01%	431
2015 Q2	–	Sell	-100,000	Closed	-$2.52M	–	456
2015 Q1	$2.52M	Buy	+100,000	New	+$2.44M	0.06%	245

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Moore Capital Management's GMED Position: Q4 2025 in Review

Moore Capital Management sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 17,087 shares — an estimated $979K sold.

Moore Capital Management first reported a position in GMED in Q1 2015 and held it in 2 quarters. The position peaked at $2.52M in Q1 2015. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

Moore Capital Management reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
Moore Capital Management sold 17,087 Globus Medical shares in Q4 2025, an estimated $979K.
Moore Capital Management first reported a position in Globus Medical in Q1 2015 and held it in 2 quarters.
Moore Capital Management's Globus Medical position peaked at $2.52M in Q1 2015.
561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Moore Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.